Key result
Pericoronary adipose tissue attenuation after PCI lacks reported clinical outcomes in the abstract.
Why the study?
PCAT attenuation on cCTA is a potential marker of coronary inflammation, but its association with clinical outcomes after PCI using current-generation DES remained to be examined.
Is pericoronary adipose tissue (PCAT) attenuation before PCI associated with clinical outcomes in patients receiving current-generation drug-eluting stents?
Observational
Is pericoronary adipose tissue (PCAT) attenuation before PCI associated with clinical outcomes in patients receiving current-generation drug-eluting stents?
The study investigates whether pre-PCI pericoronary adipose tissue attenuation on cCTA can serve as a prognostic marker for adverse clinical outcomes after DES implantation.
No takes yet. Share an insight, caveat, or question.
Results on pre-PCI PCAT attenuation and post-DES outcomes not reported; leaves open its prognostic value.
Naniwa et al. (2025) conducted an observational in Patients undergoing percutaneous coronary intervention. Pericoronary adipose tissue (PCAT) attenuation was evaluated on Patient-oriented composite endpoint (PoCE), including cardiovascular death, non-fatal myocardial infarction, any revascularisation, and stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: